NFAT activating protein with ITAM motif 1 (NFAM1) (NFAM1)

NFAT activating protein with ITAM motif 1 (NFAM1) is a type I transmembrane receptor primarily expressed on immune cells, including B cells, monocytes, and neutrophils. It is characterized by an extracellular immunoglobulin-like domain and a cytoplasmic tail containing an immunoreceptor tyrosine-based activation motif (ITAM), which is essential for its role in intracellular signal transduction. Upon activation, NFAM1 recruits and activates Syk or ZAP-70 kinases, leading to the activation of the calcineurin/NFAT pathway and the subsequent production of pro-inflammatory cytokines such as TNF-alpha and IL-13. NFAM1 has been implicated in the pathogenesis of inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, where its expression is significantly upregulated in intestinal biopsies. Additionally, it has been identified as a potential biomarker and therapeutic target for coronary artery disease due to its role in monocyte chemotaxis and atherosclerosis progression. While no approved drugs currently target NFAM1 directly, its signaling pathway is a subject of active research for the treatment of autoimmune and inflammatory disorders.

Other names

CNAIPNFAT activation molecule 1Calcineurin/NFAT-activating ITAM-containing proteinNFAT-activating protein with ITAM motif 1

NFAM1 acts as a signaling receptor that, upon activation (e.g., by ligand binding or antibody cross-linking), undergoes tyrosine phosphorylation of its cytoplasmic immunoreceptor tyrosine-based activation motif (ITAM) by Src-family kinases. This phosphorylation creates docking sites for the tandem SH2 domains of Syk or ZAP-70 kinases, which subsequently trigger the calcineurin/NFAT signaling pathway, leading to the transcription of pro-inflammatory cytokines such as TNF-alpha, IL-13, and IL-2.